SEC Form 4 · accession 0001543407-18-000046
BECTON DICKINSON & CO · BDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Kaltenbach
Officer — EVP & Pres Life Sciences
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 12:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000010795
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2018 | A | 2,533 | $0.00 | A | 2,533 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF2 | $224.94 | Jun 1, 2018 | A | 22,923 | A | Jun 1, 2019 | Jun 1, 2028 | Common Stock | 22,923 | 22,923 | D |
Explanation of responses
- F1Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
- F2The stock appreciation rights vest in four annual installments beginning June 1, 2019.